News Feature
Nature Biotechnology 25, 380 - 382 (2007)
Published online: 3 April 2007 | doi:10.1038/nbt0407-380
There is an Erratum (June 2007) associated with this News Feature.
Billion dollar babies—biotech drugs as blockbusters
Stacy Lawrence1
- Stacy Lawrence is a senior writer at BioCentury Publications
Abstract
Last year marked the first time that erythropoietins were not the top-selling biotech drugs. Stacy Lawrence looks at the biopharmaceuticals that have usurped them.
